Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06966674) titled 'No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track' on May 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Kafrelsheikh University
Condition:
No-Reflow
STEMI
Intracoronary
Tirofiban
Intervention:
Drug: Intracoronary tirofiban
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: May 12, 2025
Target Sample Size: 60
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/ct2/s...